CytomX Therapeutics (CTMX) Insider Trading & Ownership → Start loving Mondays like this (From DTI) (Ad) Free CTMX Stock Alerts $1.76 -0.10 (-5.38%) (As of 04/17/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability CytomX Therapeutics (NASDAQ:CTMX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$128,994.60 Get CTMX Insider Trade Alerts Want to know when executives and insiders are buying or selling CytomX Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CTMX Insider Buying and Selling by Quarter Ad Paradigm PressAI “wealth window” is closing soon!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… CytomX Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/19/2024Christopher OgdenSVPSell2,971$2.09$6,209.39 3/19/2024Jeffrey B LandauInsiderSell6,562$2.09$13,714.58 3/19/2024Lloyd A RowlandGeneral CounselSell5,268$2.09$11,010.12 3/19/2024Sean A MccarthyCEOSell20,223$2.09$42,266.07 12/20/2023Marcia BelvinSVPSell4,077$1.38$5,626.26 12/20/2023Sean A MccarthyCEOSell13,551$1.38$18,700.38 9/22/2023Lloyd A RowlandGeneral CounselSell5,486$1.30$7,131.80 9/22/2023Marcia BelvinSVPSell4,119$1.30$5,354.70 9/22/2023Sean A MccarthyCEOSell14,601$1.30$18,981.30 (Data available from 1/1/2013 forward) CTMX Insider Trading Activity - Frequently Asked Questions Who is on CytomX Therapeutics's Insider Roster? The list of insiders at CytomX Therapeutics includes Amy C Peterson, Carlos Campoy, Christopher Ogden, Elaine V Jones, Jeffrey B Landau, Lloyd A Rowland, Marcia Belvin, and Sean A Mccarthy. Learn more on insiders at CTMX. What percentage of CytomX Therapeutics stock is owned by insiders? 7.00% of CytomX Therapeutics stock is owned by insiders. Learn more on CTMX's insider holdings. Which CytomX Therapeutics insiders have been buying company stock? The following insider purchased CTMX shares in the last 24 months: Elaine V Jones ($7,750.00). How much insider buying is happening at CytomX Therapeutics? Insiders have purchased a total of 5,000 CTMX shares in the last 24 months for a total of $7,750.00 bought. Which CytomX Therapeutics insiders have been selling company stock? The following insiders have sold CTMX shares in the last 24 months: Amy C Peterson ($19,026.32), Carlos Campoy ($9,068.62), Christopher Ogden ($7,231.07), Jeffrey B Landau ($19,687.10), Lloyd A Rowland ($30,130.02), Marcia Belvin ($10,980.96), and Sean A Mccarthy ($114,508.85). How much insider selling is happening at CytomX Therapeutics? Insiders have sold a total of 128,668 CytomX Therapeutics shares in the last 24 months for a total of $210,632.94 sold. More Insider Trading Tools from MarketBeat Related Companies: Selecta Biosciences Insider Buying Nuvectis Pharma Insider Buying OptiNose Insider Buying Relmada Therapeutics Insider Buying Vistagen Therapeutics Insider Buying Syros Pharmaceuticals Insider Buying Repare Therapeutics Insider Buying NGM Biopharmaceuticals Insider Buying Vaccitech Insider Buying Annovis Bio Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:CTMX) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsUrgent alert: open this for a huge profit potentialTimothy SykesBiden out June 13; Kamala won’t replace him?Paradigm PressForget Nvidia, buy this A.I. Stock NowInvestorPlaceFed launches fourth dollar overhaulStansberry ResearchRevealed: The Unknown Biotech Powering AI in HealthcareBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytomX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.